Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name BLACAT1
   Synonyms BLACAT1, LINC00912, UBC1, onco-lncRNA-30, linc-UBC1, onco-lncRNA-30
   Region GRCh38_1:205434886-205437879    Sequence
   Ensembl ENSG00000281406
   RefSeq NR_103783
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name bladder cancer
   ICD-0-3 C67  
   Methods microarray, qPCR, RNAi, ISH etc.
   Sample bladder cancer tissues, cell lines (J82, UMUC-3, HT-1376, T24, 5637 etc.)
   Expression Pattern up-regulated
   Function Description

qPCR confirmed that linc-UBC1 expression is up-regulated in 60 cases (58.8%) in bladder cancer tissues compared with normal adjacent tissues, and its overexpression correlates with lymph node metastasis and poor survival. Further functional analysis demonstrated that knockdown of linc-UBC1 attenuates bladder cancer cell proliferation, motility, invasion, colony formation ability, tumorigenicity and metastatic potential. RIP and ChIP assay confirmed that linc-UBC1 physically associates with PRC2 complex and regulates histone modification status of target genes.

   Pubmed ID 23688781
   Year 2013
   Title linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer.
   External Links
   Links for  BLACAT1 GenBank       HGNC       lncrnadb       Noncode
   Links for  bladder cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.